Related Experiment Video
Updated: Mar 10, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression
Sheng-Ming Wu1,2, Syuan-Ling Lin1, Kang-Yun Lee2,3,4
1Department of Biochemistry, College of Medicine, Chang-Gung University, Taoyuan, Taiwan.
Abstract:
NEK2 (NIMA-related expressed kinase 2) is a serine/threonine centrosomal kinase that acts as a critical regulator of centrosome structure and function. Aberrant NEK2 activities lead to failure in regulating centrosome duplication. NEK2 overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers. Increased NEK2 expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (HCC) specimens. Elevated NEK2 protein is associated with poor overall survival in patients with HCC. However, the precise roles and mechanisms of NEK2 in liver cancer progression remain largely unknown. An earlier functional study revealed that NEK2 mediates drug resistance (cisplatin or lipo-doxorubicin) via expression of an ABCC10 transporter. Active angiogenesis and metastasis underlie the rapid recurrence and poor survival of HCC. Results from the current study showed that NEK2 mediates tumor growth, metastasis and angiogenesis in vivo. NEK2-mediated drug resistance was blocked by a specific PI3K or AKT inhibitor. Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-κB signaling and matrix metalloproteinase (MMP) activation. Angiogenesis was induced via the same signaling pathway and IL-8 stimulation. Our findings collectively indicate that NEK2 modulates hepatoma cell functions, including growth, drug resistance, metastasis and angiogenesis via downstream genes activation.
Insights
NIMA-related expressed kinase 2 (NEK2) drives liver cancer growth, metastasis, and drug resistance by activating key signaling pathways. Targeting NEK2 may offer new therapeutic strategies for hepatocellular carcinoma (HCC).
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- NEK2 (NIMA-related expressed kinase 2) is a centrosomal kinase regulating cell division.
- Overexpression of NEK2 is linked to tumorigenesis and poor prognosis in various cancers, including hepatocellular carcinoma (HCC).
- The specific roles of NEK2 in liver cancer progression and its underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate the functional roles and molecular mechanisms of NEK2 in liver cancer.
- To elucidate NEK2's involvement in tumor growth, metastasis, angiogenesis, and drug resistance in HCC.
- To identify downstream signaling pathways regulated by NEK2 in hepatoma cells.
Main Methods:
- Analysis of NEK2 expression in HCC datasets and patient specimens.
- In vivo studies to assess NEK2's role in tumor growth, metastasis, and angiogenesis.
- Pharmacological inhibition of PI3K/AKT pathways to investigate NEK2-mediated drug resistance.
- Examination of signaling pathways including pAKT/NF-κB, MMP activation, and IL-8 stimulation.
Main Results:
- NEK2 overexpression is detected in HCC and associated with poor survival.
- NEK2 promotes tumor growth, metastasis, and angiogenesis in vivo.
- NEK2 mediates resistance to cisplatin and lipo-doxorubicin, which can be blocked by PI3K/AKT inhibitors.
- NEK2 drives HCC cell migration and angiogenesis via the pAKT/NF-κB signaling pathway and MMP activation.
Conclusions:
- NEK2 plays a critical role in modulating multiple aspects of hepatoma cell function, including growth, drug resistance, metastasis, and angiogenesis.
- NEK2 exerts its effects through the activation of downstream signaling pathways and gene expression.
- Targeting NEK2 and its associated pathways presents a potential therapeutic strategy for HCC.
More Related Videos
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Cell Specific Gene Expression
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...